|
T35499 |
β-Amyloid (1-42), (rat/mouse) (TFA)
|
Amyloid β-peptide (1-42) (human) TFA,166090-74-0 TFA |
|
|
β-Amyloid (1-42), (rat/mouse) (TFA) is a peptide fragment consisting of 42 amino acids that can be used to study Alzheimer's disease. |
|
T7562 |
β-Amyloid (31-35)
|
β-Amyloid 31-35(TFA),β-Amyloid 31-35 |
Beta Amyloid
|
|
β-Amyloid (31-35) (β-Amyloid 31-35) is the shortest sequence of native Amyloid-β peptide. |
|
T80035 |
Biotin-β-Amyloid (1-42), human TFA
|
Biotin-amyloid β-peptide (1-42) (human) TFA |
|
|
Biotin-β-Amyloid (1-42), human TFA, also known as Biotin-Amyloid β-Peptide (1-42) (human) TFA, is a biotin-labeled 42-amino acid peptide implicated in the pathogenesis of Alzheimer's disease [1]. |
|
TP1337 |
β-Amyloid (1-42), rat TFA
|
|
|
|
β-Amyloid (1-42), rat TFA is a 42-aa peptide, shows the effects of cytotoxicity on acute hippocampal slices, and has been used in studies of alzheimer's disease. |
|
TP2171 |
β-amyloid (12-28) (TFA) (107015-83-8 free base)
|
Amyloid β-Protein (12-28) (TFA),β-amyloid (12-28) (TFA) |
Others
|
|
β-amyloid (12-28) TFA, a peptide fragment of β-amyloid protein (β1-42), is the major component of senile plaque cores. β-amyloid (12-28) has aggregation properties and the potential for Alzheimer’s disease research. |
|
T75958 |
β-Amyloid (22-35) (TFA)
|
|
|
|
β-Amyloid 22-35 (Amyloid β-Protein 22-35) TFA, a fragment comprising residues 22-35 of the β-amyloid protein, exhibits cytotoxicity towards cultured rat hippocampal neurons in serum-free media. It aggregates and forms ty... |
|
T75779 |
β-Amyloid (12-28) (TFA)
|
|
|
|
β-Amyloid (12-28) (TFA), a peptide fragment of the β-amyloid protein (β1-42)—a 42 amino acid protein primarily found in senile plaque cores—exhibits aggregation properties. This compound holds significance for research i... |
|
T75751 |
β-Amyloid (1-40) (TFA)
|
|
|
|
β-Amyloid (1-40) TFA, a principal protein in plaques observed in the brains of Alzheimer's disease patients [1], is pivotal in research focused on this neurodegenerative disorder. |
|
T75930 |
β-Amyloid (1-43)(human) TFA
|
|
|
|
β-Amyloid (1-43)(human) TFA exhibits greater aggregation tendencies and heightened toxicity compared to its well-established counterpart, Aβ1-42. Additionally, this compound demonstrates associations with both sAPPα and ... |
|
T76401 |
Amyloid β-Protein (33-42) (TFA)
|
|
|
|
Amyloid β-Protein (33-42) TFA, a fragment encompassing residues 33-42 of the β-amyloid protein, mitigates the toxicity induced by Aβ42 [1]. |
|
T75926 |
β-Amyloid (42-1), human TFA
|
|
|
|
β-Amyloid (42-1), human TFA, a 42-amino acid peptide, represents the inactive form of Amyloid β Peptide (1-42) and is pivotal in the development of Alzheimer's disease [1]. |
|
T76086 |
β-Amyloid (1-40), FAM-labeled TFA
|
|
|
|
β-Amyloid (1-40), FAM-labeled TFA is a FAM fluorescently-labelled?β-Amyloid (1-40) peptide (λ ex =?492?nm and λ em =?518?nm) [1] . |
|
T36446 |
Neuropeptide Y (human) (TFA)
|
|
|
|
Neuropeptide Y (human) TFA, a compound implicated in Alzheimer's disease (AD), exhibits protective effects against β-Amyloid toxicity in rat cortical neurons. |
|
TP1338 |
Neuropeptide Y (29-64), amide, human TFA
|
|
|
|
Neuropeptide Y (29-64), amide, human (TFA) is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity.It is showed that Neuropeptide Y (29-64), amide, human (TFA) is able to prot... |
